Stock comparison
CME Group
MSCI
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
CME
CME Group
Market cap
$106.74B
Sector
Financials
MSCI
MSCI
Market cap
$42.44B
Sector
Financials
Overall winner
MSCI MSCI
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | CME | MSCI | Winner |
|---|---|---|---|
| Warren Buffett | 70B | 80A | MSCI |
| Benjamin Graham | 69B | 71B | MSCI |
| Philip Fisher | 67B | 82A | MSCI |
| Peter Lynch | 61C | 70B | MSCI |
| Joel Greenblatt | 53C | 80A | MSCI |
| Charlie Munger | 55D | 87C | MSCI |
| Terry Smith | 57D | 88C | MSCI |
Side-by-side metrics
| Metric | CME | MSCI |
|---|---|---|
| Market cap | $106.74B | $42.44B |
| P/E (TTM) | 25.3x | 31.2x |
| EV/EBIT | 25.8x | 27.5x |
| ROIC (TTM) | 9.36% | 38.53% |
| Gross margin | 86.34% | 82.86% |
| Net margin | 62.77% | 40.74% |
| Revenue CAGR 5y | 8.59% | 11.29% |
| EPS CAGR 5y | 11.24% | 15.35% |
| Debt / Equity | 0.1x | - |
| Dividend yield | 3.75% | 1.37% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CME leads on
- Dividend yield3.75%vs 1.37%+63%
- Market cap$106.74Bvs $42.44B+60%
- Net margin62.77%vs 40.74%+35%
- P/E (TTM)25.3xvs 31.2x+19%
MSCI leads on
- Debt / Equity-vs 0.1x+105%
- ROIC (TTM)38.53%vs 9.36%+76%
- EPS CAGR 5y15.35%vs 11.24%+27%
- Revenue CAGR 5y11.29%vs 8.59%+24%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.